Zepbound vs Wegovy: Which GLP-1 Works Better for Weight Loss?

If you're exploring prescription weight loss options, you've likely come across two names: Zepbound vs Wegovy. Both medications have made headlines for their impressive results, but they're not identical. Understanding how they differ can help you make an informed decision about which might work better for your goals.

Let's break down what sets these two apart, from how they work to what you can expect in terms of results and side effects.

What Are Zepbound and Wegovy?

Both Zepbound and Wegovy belong to a class of medications called GLP-1 receptor agonists, originally developed to treat type 2 diabetes. Researchers discovered these drugs also help with significant weight loss, leading to FDA approval for weight management.

Wegovy contains semaglutide, the same active ingredient in Ozempic. It was FDA-approved for weight loss in 2021 and works by mimicking a hormone called GLP-1 that regulates appetite and blood sugar.

Zepbound contains tirzepatide, the same ingredient in Mounjaro. It received FDA approval for weight management in late 2023. Unlike Wegovy, Zepbound is a dual-action medication that targets both GLP-1 and GIP receptors, which may explain its slightly different effects.

Both are given as weekly injections and require a prescription from a licensed healthcare provider.

How Do They Work?

Understanding the mechanism behind each medication helps explain why results might vary.

Wegovy activates GLP-1 receptors in your brain and digestive system. This slows down how quickly your stomach empties, reduces appetite, and helps you feel fuller longer. The result is that you naturally eat less without the constant feeling of deprivation.

Zepbound takes things a step further. It activates both GLP-1 receptors and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual action may enhance how your body processes food and stores fat, potentially leading to greater weight loss for some people.

Think of it this way: Wegovy hits one target really well, while Zepbound hits two targets simultaneously.

Which One Shows Better Weight Loss Results?

This is the question everyone wants answered, and the clinical trial data gives us good information to work with.

In studies, Wegovy helped participants lose an average of 15-17% of their body weight over 68 weeks. For someone weighing 250 pounds, that's about 37-42 pounds.

Zepbound showed slightly higher numbers in its trials. Participants lost an average of 18-22% of their body weight over 72 weeks, depending on the dose. For that same 250-pound person, that translates to roughly 45-55 pounds.

Those are averages, though. Individual results vary widely based on factors like starting weight, diet, exercise, genetics, and how well you tolerate the medication. Some people respond better to semaglutide, while others see better results with tirzepatide.

The bottom line: both medications deliver significant weight loss, but Zepbound appears to have a slight edge in clinical trials.

Comparing Side Effects

Since both medications work similarly, they share many of the same side effects. The most common ones are gastrointestinal.

You might experience nausea, diarrhea, constipation, vomiting, or stomach discomfort, especially when starting or increasing your dose. These effects typically improve after a few weeks as your body adjusts.

In clinical trials, Zepbound had slightly higher rates of gastrointestinal side effects compared to Wegovy, likely because it's working through two pathways instead of one. However, most people find these effects manageable.

Both medications carry similar warnings about more serious but rare risks, including pancreatitis, gallbladder problems, and thyroid tumors (seen in animal studies). Your healthcare provider will review your medical history to ensure either medication is safe for you.

Cost and Accessibility Considerations

Brand-name pricing for both medications is steep. Wegovy typically costs around $1,300-$1,400 per month without insurance, while Zepbound runs about $1,000-$1,100 per month.

Insurance coverage varies significantly. Some plans cover one but not the other, and many require prior authorization or proof of medical necessity. Manufacturer savings programs can help reduce costs, but often come with eligibility restrictions.

This is where compounded versions become important. Compounded semaglutide and tirzepatide offer the same active ingredients at a fraction of the cost, making treatment accessible to more people. You can learn more about affordable options on ozarihealth.com/blog.

Which One Should You Choose?

There's no universal answer here. The "better" medication depends on your individual situation.

Consider Wegovy if you prefer a medication with a longer track record, as it's been available for weight loss since 2021. It might also be a good starting point if you're concerned about side effects, as it has slightly lower rates of gastrointestinal issues.

Consider Zepbound if you're looking for potentially greater weight loss results and don't mind the possibility of slightly more side effects. The dual-action mechanism might also benefit those who didn't get optimal results with semaglutide alone.

Ultimately, the best choice is one made in consultation with a healthcare provider who understands your medical history, weight loss goals, and how you've responded to other treatments.

Key Takeaways

• Both work: Zepbound and Wegovy are highly effective GLP-1 medications for weight loss, with clinical trials showing 15-22% body weight reduction
• Slight differences: Zepbound targets two hormone receptors (GLP-1 and GIP) while Wegovy targets one (GLP-1), which may explain Zepbound's slightly higher weight loss in studies
• Similar side effects: Both medications commonly cause nausea and digestive issues, especially early on, with Zepbound showing slightly higher rates
• Cost matters: Brand-name versions are expensive, but compounded alternatives make these medications more accessible at significantly lower prices

Frequently Asked Questions

Can I switch from Wegovy to Zepbound or vice versa?

Yes, many people switch between these medications based on how well they respond or tolerate each one. Your healthcare provider can guide you through the transition and help determine the appropriate starting dose. There's typically a brief adjustment period when switching, but most people transition smoothly.

How long does it take to see results with Zepbound or Wegovy?

Most people start noticing reduced appetite within the first week or two. Visible weight loss typically becomes apparent within the first month, with continued progress over the following months. Peak results usually occur around 60-72 weeks. Remember that both medications work best when combined with healthy eating habits and regular physical activity.

Are compounded versions of these medications as effective as the brand names?

Compounded semaglutide and tirzepatide contain the same active ingredients as Wegovy and Zepbound. They're prepared by licensed compounding pharmacies following FDA guidelines. While compounded medications don't go through the same FDA approval process as brand-name drugs, they offer a more affordable option for people who otherwise couldn't access these treatments. Always work with a reputable provider who sources from accredited compounding pharmacies.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed providers and shipped to your door. Learn more at ozarihealth.com.

Reviewed by the Ozari Clinical Content Team (OCCT) — health writers and wellness professionals specializing in GLP-1 therapy and metabolic health. This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.